Skip to main content

Technescan MAG3

Generic: Technescan Tc 99m Mertiatide

Verified·Apr 23, 2026
Manufacturer
Curium
NDC
69945-096
Route
INTRAVENOUS
ICD-10 indication
N28.9

Affordability Check

How much will you actually pay for Technescan MAG3?

In 30 seconds, see every legitimate way to afford Technescan MAG3 — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Technescan MAG3

What is this medication?

Technescan MAG3 is a radioactive diagnostic agent, specifically a radiopharmaceutical containing technetium Tc 99m mertiatide, used in medical imaging procedures known as renal scintigraphy. It is administered via intravenous injection to help healthcare providers visualize the structure and function of the kidneys. By tracking the movement of the medication through the renal system with a gamma camera, doctors can obtain detailed information about kidney blood flow and the production and drainage of urine.

This medication is primarily used to evaluate a wide range of renal conditions, including suspected urinary tract obstructions, kidney scarring, and overall renal performance. It is also a valuable tool for monitoring the health and functionality of a transplanted kidney to ensure it is working correctly. Because it provides dynamic images of the kidneys in real-time, it helps clinicians diagnose various disorders and determine the most appropriate course of treatment for patients with potential kidney issues.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Technescan MAG3. Official source: DailyMed (NLM) · Label effective Jan 6, 2026

Indications and usage
INDICATIONS AND USAGE Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.
Dosage and administration
DOSAGE AND ADMINISTRATION The suggested dose range employed in the average adult patient (70 kg) for renal function and imaging studies is 185 MBq (5 mCi) to 370 MBq (10 mCi). In pediatric patients the recommended dose range is 2.6 MBq/kg (70 μCi/kg) to 5.2 MBq/kg (140 μCi/kg) with a minimum dose of 37 MBq (1 mCi). The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Aseptic procedures and a shielded syringe should be employed in withdrawing doses for administration to patients. The user should wear waterproof gloves during the administration procedure.
Contraindications
CONTRAINDICATIONS None known.
Warnings
WARNINGS None known.
Adverse reactions
ADVERSE REACTIONS The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.
Use in pregnancy
Pregnancy Animal reproduction studies have not been conducted with technetium Tc 99m mertiatide. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Technetium Tc 99m mertiatide should be given to a pregnant woman only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.